Akela Pharma, Inc. Announces Completion of Asset Foreclosure on Formulation Technologies, LLC

VANCOUVER, March 14, 2013 /CNW Telbec/ - Akela Pharma, Inc. (the "Corporation") has announced that the asset foreclosure on its wholly owned subsidiary, Formulation Technologies, LLC d/b/a PharmaForm, was completed on March 9, 2013. The Corporation and its subsidiaries have ceased operations. All employees, officers and directors of the Corporation have resigned or been terminated.


For further information:

Akela Pharma, Inc.
Tel: 512-531-6676

Organization Profile

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890